Loading organizations...
Loading organizations...
Noninvasive blood-based diagnostic tests for cancer assessment.
OncoCell MDx has raised $22.2M across 1 funding round.
OncoCell MDx has raised $22.2M in total across 1 funding round.
OncoCell MDx has raised $22.2M in total across 1 funding round.
OncoCell MDx's investors include Andrew Midler.
OncoCell MDx has raised $22.2M across 1 funding round. Most recently, it raised $22.2M Series B in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 11, 2019 | $22.2M Series B | Andrew Midler |